EARLY DETECTION SAVES LIVES!!! 

DITI’s key role as an adjust tool in breast cancer & other breast disorders is to aid in the early detection and monitoring of abnormal physiology & the establishment of risk factors for the development or existence of disease or dysfunction. DITI detects the subtle physiologic changes that accompany breast pathology whether it is cancer, fibrocystic disease, vascular disease or infection.  The imaging procedure is painless, 100% non invasive, and emits zero radiation. All positive thermal findings must be correlated with structural testing and clinical correlation and no breast screening modality is 100% accurate.  Southwest Medical Imaging & Ultrasound strongly encourages the inclusion of your physician and a multi-modality approach to breast health. 

ULTRASOUND

Ultrasound safely measures the density of tissues in the breast without radiation or risk and is able to provide an anatomical structure of an existing or developing pathology. Our comprehensive breast sonography includes bilateral scans of the breast and axillary regions.

Breast ultrasound is a noninvasive diagnostic exam that assesses breast tissue through images produced by the use of sounds waves. It may be used as a screening tool or to investigate abnormal findings from a physical exam or other testing. Ultrasound is the best way to find out if an abnormality is solid (such as a benign fibroadenoma or cancer) or fluid-filled (such as a benign cyst). Ultrasound may also be used to assess blood flow to areas inside the breasts. This diagnostic method is able to measure the exact size and location of the lump and evaluate the surrounding tissue. Ultrasounds are beneficial, for women with dense breast tissue where mammograms may be less accurate or for those wishing to avoid radiation. Ultrasound cannot determine cancer in a lump or cyst this is achieved only through biopsy; nor can it detect calcifications. Calcifications are only detected through mammography.

None of the breast imaging modalities available (Mammography, Thermography, Sonography or MRI) has a 100 % accuracy rate. Comprehensive breast screening to include a combination of structural and physiological testing is strongly encouraged. Consultation with your health care provider to determine the best combination of scans is recommended.

Active Cancer Cells Double in Number every 90 days

90 days——–2 cells
1 year———16 cells *detectable by thermography at this stage
2 years——–256 cells
3 years——-4,896 cells
4 years——-65,536 cells
5 years——1,048,576 cells *still undetectable by mammography at this stage
6 years——16,777,216 cells
7 years—–268,435,456 cells
8 years——4,294,967 cells * 32 doublings *normally detected by mammography at this stage

40 DOUBLINGS (APPROXIMATELY 10 YEARS) IS CONSIDERED LETHAL

It takes years for a tumor to grow. Therefore, the earliest possible indication of abnormality is needed to allow for the earliest possible treatment and prevention.

All women can benefit from DITI breast imaging. It is especially appropriate for younger women, ages 30-50 whose denser breast tissue makes it difficult for mammography to be effective. This test can provide a clinical marker to the doctor or mammographer that a specific area of the breast needs particularly close examination.

Breast cancers tend to grow significantly faster in younger women under 50:

Source: Cancer 71:3547-3551, 1993

A routine annual breast scan looks for vascular changes in the same way that an annual pap smear looks for cellular changes.

DITI must be used in conjunction with a multi-modality approach, breast self exam, routine breast exams with your practitioner and mammography, the best possible evaluation of breast health is made.

INCREASE YOUR CHANCES OF DETECTING BREAST CANCER IN ITS EARLIEST STAGES